Skip to search boxSkip to navigationSkip to main content

ANCA-Positive pauci-immune crescentic glomerulonephritis in a patient with systemic lupus erythematosus

  • Percy Herrera-Añazco
    ,
  • Percy Velásquez-Castillo
    ,
  • ,
  • Germán Valenzuela-Rodriguez
    ,
  • Carmen Asato-Higa
  • Universidad San Ignacio de Loyola
    ,
  • Hospital Nacional Dos de Mayo
    ,
  • Universidad Nacional del Altiplano
    ,
  • Clínica Delgado
Research Output: Contribution to journal Article Peer-review

Open access

Publication Information

Output type

Research Output: Contribution to journal Article Peer-review

Original language

English

Pages from-to (Number of pages)

Pages 454-457 (4 pages)

Journal (Volume, Issue Number)

Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia (Volume 39, Issue 4)

Publication milestones

  • Published - 01/10/2017

Publication status

Published - 01/10/2017

ISSN

0101-2800

Publication IDs

  • Scopus: 85053562729
  • PubMed: 29319773

Abstract

The pauci-immune crescentic glomerulonephritis (PICGN) is generally associated with small-vessel vasculitis with a few reported cases associated with other autoimmune diseases such as Systemic Lupus Erythematosus (SLE). We present the case of a female 34-year-old patient with acute kidney injury symptoms with indication for renal replacement therapy in the context of clinical SLE diagnosis. A kidney biopsy was conducted and it was found that most glomeruli showed some segmental sclerosis with synechia to the Bowman's capsule. 67% of the glomeruli had fibroepithelial crescents. Moreover, the interstitial space had a moderate lymphomononuclear infiltration and mild fibrosis. In the arterioles, there were walls thickened by subintimal sclerosis. Direct immunofluorescence detected limited IgM and C3 deposits in capillary loops and negative mensangium for IgG, IgA and C1q. A therapy using corticosteroids and intravenous cyclophosphamide was initiated with stable evolution. PICGN associated with SLE is a rare pathology with clinical presentation, varied evolution and without a standard medical treatment.